IKZF3 and plasma cell myeloma: Avadomide (CC-122) is another glutarimide-based cereblon modulator that has broader activity than lenalidomide, possibly due to its capacity to cause deeper and faster kinetics of Aiolos degradation in myeloma cell lines [29].